Bayer settles some NSF cases

Article

Radiology ‘Wikipedia’ settles in on web

Bayer settles some NSF cases

Bayer has tentatively settled between 30 and 40 lawsuits brought by patients who developed nephrogenic systemic fibrosis after the administration of Magnevist, its MR contrast agent. Only Bayer has so far reached any such settlements, according to Peter Burg, an attorney with Burg Simpson Eldredge Hersh & Jardine in Englewood, CO, who told DI SCAN that not all of the tentative deals involve his clients. Bayer and several other makers of gadolinium-based contrast agents are facing hundreds of lawsuits alleging a link between the administration of the agents and NSF, a potentially fatal disease characterized by uncontrolled growth of connective tissue in the skin and internal organs. In September 2007, the FDA asked manufacturers of these agents -- Bayer (Magnevist), GE Healthcare (Omniscan), Mallinckrodt/Tyco Healthcare (OptiMark), and Bracco Diagnostics (ProHance and MultiHance) -- to add a black-box warning about NSF. The agency at the time also warned patients with impaired kidney function to avoid gadolinium-containing agents.

Radiology ‘Wikipedia' settles in on web

A specialist version of Wikipedia aimed at the radiology community is on the web. Radiopaedia.org is a free online radiology resource built and maintained by users, who find and correct errors. Currently in beta form, Radiopaedia.org is being framed as the means to support discussion of difficult or controversial topics. Images and other materials can be submitted and downloaded for use by others under Creative Commons 3.0 license.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.